ERBB2 and breast carcinoma: By treating HER2+ breast cancer cells with MNP-HC, we observed an increase in the ratio between Y1248-phosphorylated and total HER2 protein in MDA-MB-453 (Fig. 2A) and SKBR3 cells (Fig. 2B).